Review article · 2015 · Open access
Targeting cancer with kinase inhibitors
Journal of Clinical Investigation, 125(5), 1780–1789 · Published 30 April 2015 · DOI 10.1172/jci76094
In brief
“Targeting cancer with kinase inhibitors” is a 2015 review article by Stefan David Gross and 4 co-authors, published in Journal of Clinical Investigation. OpenAlex counts 496 citations as of 19 November 2026. It is open access: the full text is free to read at Journal of Clinical Investigation.
- Citations
- 496
- Most cited in
- 2017 (69)
- Field-weighted impact
- 4.72
- References
- 148
- Authors
- 5
Abstract
Kinase inhibitors have played an increasingly prominent role in the treatment of cancer and other diseases. Currently, more than 25 oncology drugs that target kinases have been approved, and numerous additional therapeutics are in various stages of clinical evaluation. In this Review, we provide an in-depth analysis of activation mechanisms for kinases in cancer, highlight recent successes in drug discovery, and demonstrate the clinical impact of selective kinase inhibitors. We also describe the substantial progress that has been made in designing next-generation inhibitors to circumvent on-target resistance mechanisms, as well as ongoing strategies for combining kinase inhibitors in the clinic. Last, there are numerous prospects for the discovery of novel kinase targets, and we explore cancer immunotherapy as a new and promising research area for studying kinase biology.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Gross, S. D., Rahal, R., Stransky, N., Lengauer, C., & Hoeflich, K. P. (2015). Targeting cancer with kinase inhibitors. Journal of Clinical Investigation, 125(5), 1780–1789. https://doi.org/10.1172/jci76094
MLA 9
Gross, Stefan David, et al. “Targeting cancer with kinase inhibitors.” Journal of Clinical Investigation, vol. 125, no. 5, 2015, pp. 1780–1789. https://doi.org/10.1172/jci76094.
Chicago
Gross, Stefan David, Rami Rahal, Nicolas Stransky, Christoph Lengauer, and Klaus P. Hoeflich. 2015. “Targeting cancer with kinase inhibitors.” Journal of Clinical Investigation 125 (5): 1780–1789. https://doi.org/10.1172/jci76094.
Harvard
Gross, S. D. et al. (2015) ‘Targeting cancer with kinase inhibitors’, Journal of Clinical Investigation, 125(5), pp. 1780–1789. doi:10.1172/jci76094.
IEEE
S. D. Gross, R. Rahal, N. Stransky, C. Lengauer, and K. P. Hoeflich, “Targeting cancer with kinase inhibitors,” Journal of Clinical Investigation, vol. 125, no. 5, pp. 1780–1789, 2015, doi: 10.1172/jci76094.
BibTeX
@article{gross2015targeting,
title = {{Targeting cancer with kinase inhibitors}},
author = {Gross, Stefan David and Rahal, Rami and Stransky, Nicolas and Lengauer, Christoph and Hoeflich, Klaus P.},
journal = {Journal of Clinical Investigation},
year = {2015},
volume = {125},
number = {5},
pages = {1780--1789},
doi = {10.1172/jci76094},
url = {https://doi.org/10.1172/jci76094}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 69 | |
| 2018 | 55 | |
| 2019 | 66 | |
| 2020 | 59 | |
| 2021 | 64 | |
| 2022 | 45 | |
| 2023 | 33 | |
| 2024 | 28 | |
| 2025 | 24 | |
| 2026 | 19 |
Its field-weighted citation impact is 4.72: it has been cited 4.72 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- kinase inhibitors
- cancer therapy
- kinase activation mechanism
- combination therapy
- cancer immunotherapy
- anticancer drug development
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Gross, S. D., Rahal, R., Stransky, N., Lengauer, C., & Hoeflich, K. P. (2015). Targeting cancer with kinase inhibitors. Journal of Clinical Investigation, 125(5), 1780–1789. https://doi.org/10.1172/jci76094
How many times has this paper been cited?
496 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Journal of Clinical Investigation: sign in and open the PDF from this page.
Who wrote this paper?
Stefan David Gross, Rami Rahal, Nicolas Stransky, Christoph Lengauer, Klaus P. Hoeflich.
What is the DOI of this paper?
10.1172/jci76094, permanently at https://doi.org/10.1172/jci76094. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.